TY - JOUR AU - Rosenberg, M. E. AU - Silkensen, J. PY - 1995 DA - 1995// TI - Clusterin: physiologic and pathophysiologic considerations JO - Int J Biochem Cell Biol VL - 27 UR - https://doi.org/10.1016/1357-2725(95)00027-M DO - 10.1016/1357-2725(95)00027-M ID - Rosenberg1995 ER - TY - JOUR AU - Rohne, P. AU - Prochnow, H. AU - Koch-Brandt, C. PY - 2016 DA - 2016// TI - The CLU-files: disentanglement of a mystery JO - Biomol Concepts VL - 7 UR - https://doi.org/10.1515/bmc-2015-0026 DO - 10.1515/bmc-2015-0026 ID - Rohne2016 ER - TY - JOUR AU - Scaltriti, M. AU - Bettuzzi, S. AU - Sharrard, R. M. AU - Caporali, A. AU - Caccamo, A. E. AU - Maitland, N. J. PY - 2004 DA - 2004// TI - Clusterin overexpression in both malignant and nonmalignant prostate epithelial cells induces cell cycle arrest and apoptosis JO - Br J Cancer VL - 91 UR - https://doi.org/10.1038/sj.bjc.6602193 DO - 10.1038/sj.bjc.6602193 ID - Scaltriti2004 ER - TY - JOUR AU - Muhammad, L. A. AU - Saad, F. PY - 2015 DA - 2015// TI - The role of clusterin in prostate cancer: treatment resistance and potential as a therapeutic target JO - Expert Rev Anticancer Ther VL - 15 UR - https://doi.org/10.1586/14737140.2015.1064769 DO - 10.1586/14737140.2015.1064769 ID - Muhammad2015 ER - TY - JOUR AU - Yom, C. K. AU - Woo, H. Y. AU - Min, S. Y. AU - Kang, S. Y. AU - Kim, H. S. PY - 2009 DA - 2009// TI - Clusterin overexpression and relapse-free survival in breast cancer JO - Anticancer Res VL - 29 ID - Yom2009 ER - TY - JOUR AU - Flanagan, L. AU - Whyte, L. AU - Chatterjee, N. AU - Tenniswood, M. PY - 2010 DA - 2010// TI - Effects of clusterin over-expression on metastatic progression and therapy in breast cancer JO - BMC Cancer VL - 10 UR - https://doi.org/10.1186/1471-2407-10-107 DO - 10.1186/1471-2407-10-107 ID - Flanagan2010 ER - TY - JOUR AU - Gomaa, W. AU - Al-Ahwal, M. AU - Al-Maghrabi, H. AU - Buhmeida, A. AU - Al-Qahtani, M. AU - Al-Maghrabi, B. PY - 2017 DA - 2017// TI - Expression of clusterin in colorectal carcinoma in relation to clinicopathological criteria JO - Malays J Pathol VL - 39 ID - Gomaa2017 ER - TY - JOUR AU - Albert, J. M. AU - Gonzalez, A. AU - Massion, P. P. AU - Chen, H. AU - Olson, S. J. AU - Shyr, Y. PY - 2007 DA - 2007// TI - Cytoplasmic clusterin expression is associated with longer survival in patients with resected non small cell lung cancer JO - Cancer Epidemiol Biomark Prev VL - 16 UR - https://doi.org/10.1158/1055-9965.EPI-07-0146 DO - 10.1158/1055-9965.EPI-07-0146 ID - Albert2007 ER - TY - JOUR AU - Wang, Y. AU - Brodsky, A. S. AU - Xiong, J. AU - Lopresti, M. L. AU - Yang, D. AU - Resnick, M. B. PY - 2018 DA - 2018// TI - Stromal Clusterin expression predicts therapeutic response to Neoadjuvant chemotherapy in triple negative breast cancer JO - Clin Breast Cancer VL - 18 UR - https://doi.org/10.1016/j.clbc.2017.08.007 DO - 10.1016/j.clbc.2017.08.007 ID - Wang2018 ER - TY - JOUR AU - Kim, Y. S. AU - Jin, H. O. AU - Hong, S. E. AU - Song, J. Y. AU - Hwang, C. S. AU - Park, I. C. PY - 2018 DA - 2018// TI - Silencing of secretory clusterin sensitizes NSCLC cells to V-ATPase inhibitors by downregulating survivin JO - Biochem Biophys Res Commun VL - 495 UR - https://doi.org/10.1016/j.bbrc.2017.12.077 DO - 10.1016/j.bbrc.2017.12.077 ID - Kim2018 ER - TY - JOUR AU - Wang, X. AU - Zou, F. AU - Zhong, J. AU - Yue, L. AU - Wang, F. AU - Wei, H. PY - 2018 DA - 2018// TI - Secretory Clusterin mediates Oxaliplatin resistance via the Gadd45a/PI3K/Akt signaling pathway in hepatocellular carcinoma JO - J Cancer VL - 9 UR - https://doi.org/10.7150/jca.23849 DO - 10.7150/jca.23849 ID - Wang2018 ER - TY - JOUR AU - Lai, J. P. AU - Chen, Z. M. AU - Lok, T. AU - Chan, O. T. AU - Himmelfarb, E. AU - Zhai, Q. PY - 2014 DA - 2014// TI - Immunohistochemical stains of proliferating cell nuclear antigen, insulin-like growth factor 2 and clusterin help distinguish malignant from benign liver nodular lesions JO - J Clin Pathol VL - 67 UR - https://doi.org/10.1136/jclinpath-2013-201907 DO - 10.1136/jclinpath-2013-201907 ID - Lai2014 ER - TY - JOUR AU - Lin, F. AU - Shi, J. AU - Wang, H. L. AU - Ma, X. J. AU - Monroe, R. AU - Luo, Y. PY - 2018 DA - 2018// TI - Detection of albumin expression by RNA in situ hybridization is a sensitive and specific method for identification of hepatocellular carcinomas and intrahepatic Cholangiocarcinomas JO - Am J Clin Pathol VL - 150 UR - https://doi.org/10.1093/ajcp/aqy030 DO - 10.1093/ajcp/aqy030 ID - Lin2018 ER - TY - JOUR AU - Wang, H. L. AU - Kim, C. J. AU - Koo, J. AU - Zhou, W. AU - Choi, E. K. AU - Arcega, R. PY - 2017 DA - 2017// TI - Practical immunohistochemistry in neoplastic pathology of the gastrointestinal tract, liver, biliary tract, and pancreas JO - Arch Pathol Lab Med VL - 141 UR - https://doi.org/10.5858/arpa.2016-0489-RA DO - 10.5858/arpa.2016-0489-RA ID - Wang2017 ER - TY - JOUR AU - Wang, H. L. AU - Anatelli, F. AU - Zhai, Q. J. AU - Adley, B. AU - Chuang, S. T. AU - Yang, X. J. PY - 2008 DA - 2008// TI - Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions JO - Arch Pathol Lab Med VL - 132 ID - Wang2008 ER - TY - JOUR AU - Liu, X. AU - Wang, S. K. AU - Zhang, K. AU - Zhang, H. AU - Pan, Q. AU - Liu, Z. PY - 2015 DA - 2015// TI - Expression of glypican 3 enriches hepatocellular carcinoma development-related genes and associates with carcinogenesis in cirrhotic livers JO - Carcinogenesis. VL - 36 UR - https://doi.org/10.1093/carcin/bgu245 DO - 10.1093/carcin/bgu245 ID - Liu2015 ER - TY - JOUR AU - Kang, Y. K. AU - Hong, S. W. AU - Lee, H. AU - Kim, W. H. PY - 2004 DA - 2004// TI - Overexpression of clusterin in human hepatocellular carcinoma JO - Hum Pathol VL - 35 UR - https://doi.org/10.1016/j.humpath.2004.07.021 DO - 10.1016/j.humpath.2004.07.021 ID - Kang2004 ER - TY - JOUR AU - Lau, S. H. AU - Sham, J. S. AU - Xie, D. AU - Tzang, C. H. AU - Tang, D. AU - Ma, N. PY - 2006 DA - 2006// TI - Clusterin plays an important role in hepatocellular carcinoma metastasis JO - Oncogene. VL - 25 UR - https://doi.org/10.1038/sj.onc.1209141 DO - 10.1038/sj.onc.1209141 ID - Lau2006 ER - TY - JOUR AU - Chen, Z. M. AU - Crone, K. G. AU - Watson, M. A. AU - Pfeifer, J. D. AU - Wang, H. L. PY - 2005 DA - 2005// TI - Identification of a unique gene expression signature that differentiates hepatocellular adenoma from well-differentiated hepatocellular carcinoma JO - Am J Surg Pathol VL - 29 UR - https://doi.org/10.1097/01.pas.0000176426.21876.a5 DO - 10.1097/01.pas.0000176426.21876.a5 ID - Chen2005 ER - TY - JOUR AU - Ahuja, A. AU - Gupta, N. AU - Kalra, N. AU - Srinivasan, R. AU - Chawla, Y. AU - Rajwanshi, A. PY - 2008 DA - 2008// TI - Role of CD10 immunochemistry in differentiating hepatocellular carcinoma from metastatic carcinoma of the liver JO - Cytopathology. VL - 19 UR - https://doi.org/10.1111/j.1365-2303.2007.00520.x DO - 10.1111/j.1365-2303.2007.00520.x ID - Ahuja2008 ER - TY - JOUR AU - Saad, R. S. AU - Luckasevic, T. M. AU - Noga, C. M. AU - Johnson, D. R. AU - Silverman, J. F. AU - Liu, Y. L. PY - 2004 DA - 2004// TI - Diagnostic value of HepPar1, pCEA, CD10, and CD34 expression in separating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration cytology JO - Diagn Cytopathol VL - 30 UR - https://doi.org/10.1002/dc.10345 DO - 10.1002/dc.10345 ID - Saad2004 ER - TY - JOUR AU - Borscheri, N. AU - Roessner, A. AU - Rocken, C. PY - 2001 DA - 2001// TI - Canalicular immunostaining of neprilysin (CD10) as a diagnostic marker for hepatocellular carcinomas JO - Am J Surg Pathol VL - 25 UR - https://doi.org/10.1097/00000478-200110000-00011 DO - 10.1097/00000478-200110000-00011 ID - Borscheri2001 ER -